NOV 20, 2013 9:00 AM PST

Pharma/Diagnostic Partnerships in Companion Diagnostic Development

Speaker

Abstract
The development of CDx assays minimally requires a partnership between a pharmaceutical and a diagnostic company. It is not uncommon for the drug to be developed through an alliance of two pharmaceutical companies, and diagnostic assay development programs may include separate companies for design of the assay and development of the platform. To ensure effective delivery of the CDx within this complex environment, highly matrixed teams must be formed to address strategic and technical issues, and to deliver a quality product coordinated with the drug development schedule.

Show Resources
You May Also Like
APR 07, 2020 8:00 AM PDT
C.E. CREDITS
APR 07, 2020 8:00 AM PDT
DATE: April 7, 2020 TIME: 8:00am PT, 11:00am ET This webinar sets out to establish why quality control is key to robust, reliable, reproducible science. We will look at best practice criteri...
JAN 23, 2020 9:00 AM PST
C.E. CREDITS
JAN 23, 2020 9:00 AM PST
DATE: January 23, 2020 TIME: 9:00am PST, 12:00pm EST...
JUN 09, 2020 10:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
C.E. CREDITS
JUN 09, 2020 10:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
DATE: June 9, 2020 TIME: 10:00am PT, 1:00pm ET The presentation will first discuss sepsis as a disease and then explain the importance of performing diagnostic tests in the clinical labora...
APR 27, 2020 9:00 AM PDT
C.E. CREDITS
APR 27, 2020 9:00 AM PDT
DATE: April 27, 2020 TIME: 9:00am PT, 12:00pm ET Recombinant adeno-associated virus (rAAV) is a small (25-nm) virus that is composed of a protein shell called a capsid and a single-stranded...
MAY 04, 2020 9:00 AM PDT
C.E. CREDITS
MAY 04, 2020 9:00 AM PDT
DATE: May 4, 2020 TIME: 9:00am PT, 12:00pm ET...
MAR 27, 2020 11:00 AM PDT
C.E. CREDITS
MAR 27, 2020 11:00 AM PDT
DATE: March 27, 2020 TIME: 11:00am PT, 2:00pm ET Adeno-associated virus (AAV) is one of the most commonly used delivery vehicles in gene therapy development. However, the presence of product...
Loading Comments...
Show Resources